Plain-English translation of NCT06594289 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying a new surgical technique for people undergoing minimally invasive (laparoscopic) liver surgery to remove tumors. Researchers are comparing two approaches: the standard method of controlling blood flow during surgery versus a newer method that combines blood flow restriction with a different fluid management strategy. The goal is to see if the new approach reduces bleeding, shortens surgery time, and improves how well the surgeon and anesthesiologist work together.
During liver surgery, controlling bleeding is critical but can be challenging. The standard approach requires the anesthesiologist to use certain medications to manage blood pressure and fluid levels. This trial is exploring whether a newer surgical technique, combined with a more flexible fluid management strategy, can control bleeding more effectively while reducing the need for these medications and improving patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to one of two surgical groups. Both groups will receive laparoscopic liver surgery using the Pringle method (a standard blood flow control technique). One group will have surgery with standard fluid management and blood pressure medications as needed, while the other group will have surgery with a different fluid management approach and a new blood flow restriction technique. The research team will monitor your blood pressure, blood loss, surgery time, and other medical markers during and after surgery, with follow-up assessments at 3 days post-operation and beyond.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China